These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36548010)

  • 1. Differences in the distribution of pathogens and antimicrobial resistance in bloodstream infections in migrants compared with non-migrants in Denmark.
    Nielsen RT; Andersen CØ; Schønheyder HC; Petersen JH; Knudsen JD; Jarløv JO; Norredam M
    Infect Dis (Lond); 2023 Mar; 55(3):165-174. PubMed ID: 36548010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic resistance patterns of Escherichia coli in migrants vs non-migrants: a study of 14 561 urine samples.
    Sloth LB; Nielsen RT; Østergaard C; Nellums LB; Hargreaves S; Friedland JS; Norredam M
    J Travel Med; 2019 Dec; 26(8):. PubMed ID: 31651032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogen distribution and antimicrobial resistance in infections in migrants and nonmigrants in Denmark, a cross-sectional study.
    Nielsen RT; Köse G; Sloth L; Andersen CØ; Petersen JH; Norredam M
    Trop Med Int Health; 2022 Nov; 27(11):999-1008. PubMed ID: 36148529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.
    Mehl A; Åsvold BO; Kümmel A; Lydersen S; Paulsen J; Haugan I; Solligård E; Damås JK; Harthug S; Edna TH
    BMC Infect Dis; 2017 Feb; 17(1):116. PubMed ID: 28148226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014.
    Bou-Antoun S; Davies J; Guy R; Johnson AP; Sheridan EA; Hope RJ
    Euro Surveill; 2016 Sep; 21(35):. PubMed ID: 27608263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis on distribution and drug resistance of pathogen caused community-onset bloodstream infection].
    Mao S; Ge Z; Zhao H; Cao J; Xia Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jan; 31(1):67-72. PubMed ID: 30707872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates.
    Ramsey EG; Royer J; Bookstaver PB; Justo JA; Kohn J; Albrecht H; Al-Hasan MN
    Int J Antimicrob Agents; 2019 Jul; 54(1):1-7. PubMed ID: 30885805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998-2016: a study of electronic health records.
    Vihta KD; Stoesser N; Llewelyn MJ; Quan TP; Davies T; Fawcett NJ; Dunn L; Jeffery K; Butler CC; Hayward G; Andersson M; Morgan M; Oakley S; Mason A; Hopkins S; Wyllie DH; Crook DW; Wilcox MH; Johnson AP; Peto TEA; Walker AS
    Lancet Infect Dis; 2018 Oct; 18(10):1138-1149. PubMed ID: 30126643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bloodstream infections with
    Zhong Y; Zhang X; Liu W; Yang F; Yan Q; Liu Q; Li Y; Li H; Zou M
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1521-1526. PubMed ID: 30613024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of migration on the incidence and mortality of bloodstream infection: a Danish register-based cohort study.
    Nielsen RT; Norredam M; Schønheyder HC; Petersen JH; Knudsen JD; Jarløv JO; Andersen CØ
    Clin Microbiol Infect; 2021 Oct; 27(10):1474-1480. PubMed ID: 33549766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007.
    Al-Hasan MN; Lahr BD; Eckel-Passow JE; Baddour LM
    J Antimicrob Chemother; 2009 Jul; 64(1):169-74. PubMed ID: 19435736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of community-onset extended-spectrum β-lactamase-producing
    Richelsen R; Smit J; Anru PL; Schønheyder HC; Nielsen H
    Infect Dis (Lond); 2020 Aug; 52(8):547-556. PubMed ID: 32401562
    [No Abstract]   [Full Text] [Related]  

  • 13. E. coli bacteraemia and antimicrobial resistance following antimicrobial prescribing for urinary tract infection in the community.
    McCowan C; Bakhshi A; McConnachie A; Malcolm W; Barry SJ; Santiago VH; Leanord A
    BMC Infect Dis; 2022 Oct; 22(1):805. PubMed ID: 36307776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
    De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies.
    Fasugba O; Gardner A; Mitchell BG; Mnatzaganian G
    BMC Infect Dis; 2015 Nov; 15():545. PubMed ID: 26607324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial pathogens and resistance causing community acquired paediatric bloodstream infections in low- and middle-income countries: a systematic review and meta-analysis.
    Droz N; Hsia Y; Ellis S; Dramowski A; Sharland M; Basmaci R
    Antimicrob Resist Infect Control; 2019; 8():207. PubMed ID: 31893041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of ertapenem, ciprofloxacin, ceftriaxone, piperacillin-tazobactam, and ampicillin-sulbactam against 12 common clinical isolates of community-acquired bacteremia.
    Hwang KP; Tang YF; Shen YH
    J Microbiol Immunol Infect; 2009 Oct; 42(5):433-8. PubMed ID: 20182674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region.
    Laupland KB; Gregson DB; Church DL; Ross T; Pitout JD
    Clin Microbiol Infect; 2008 Nov; 14(11):1041-7. PubMed ID: 19040476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
    Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; de Cueto M; Ríos MJ; Hernández JR; Pascual A
    Clin Infect Dis; 2006 Dec; 43(11):1407-14. PubMed ID: 17083012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.